These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 18282123)

  • 1. High-dimensional biology to comprehend hepatocellular carcinoma.
    Vivekanandan P; Singh OV
    Expert Rev Proteomics; 2008 Feb; 5(1):45-60. PubMed ID: 18282123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central genetic alterations common to all HCV-positive, HBV-positive and non-B, non-C hepatocellular carcinoma: a new approach to identify novel tumor markers.
    Kurokawa Y; Honma K; Takemasa I; Nakamori S; Kita-Matsuo H; Motoori M; Nagano H; Dono K; Ochiya T; Monden M; Kato K
    Int J Oncol; 2006 Feb; 28(2):383-91. PubMed ID: 16391793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative and integrative functional genomics of HCC.
    Lee JS; Thorgeirsson SS
    Oncogene; 2006 Jun; 25(27):3801-9. PubMed ID: 16799621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hcc-2, a novel mammalian ER thioredoxin that is differentially expressed in hepatocellular carcinoma.
    Nissom PM; Lo SL; Lo JC; Ong PF; Lim JW; Ou K; Liang RC; Seow TK; Chung MC
    FEBS Lett; 2006 Apr; 580(9):2216-26. PubMed ID: 16574106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving 'omics' technologies for diagnostics of head and neck cancer.
    Nagaraj NS
    Brief Funct Genomic Proteomic; 2009 Jan; 8(1):49-59. PubMed ID: 19273537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current advances in tumor proteomics and candidate biomarkers for hepatic cancer.
    Peng XQ; Wang F; Geng X; Zhang WM
    Expert Rev Proteomics; 2009 Oct; 6(5):551-61. PubMed ID: 19811076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward the discovery of new biomarkers of hepatocellular carcinoma by proteomics.
    Santamaría E; Muñoz J; Fernández-Irigoyen J; Prìeto J; Corrales FJ
    Liver Int; 2007 Mar; 27(2):163-73. PubMed ID: 17311610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative genomic classification of human hepatocellular carcinoma].
    Kaposi-Novák P
    Magy Onkol; 2009 Mar; 53(1):61-7. PubMed ID: 19318328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined serum and tissue proteomic study applied to a c-Myc transgenic mouse model of hepatocellular carcinoma identified novel disease regulated proteins suitable for diagnosis and therapeutic intervention strategies.
    Ritorto MS; Borlak J
    J Proteome Res; 2011 Jul; 10(7):3012-30. PubMed ID: 21644509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular classification of hepatocellular carcinoma anno 2011.
    van Malenstein H; van Pelt J; Verslype C
    Eur J Cancer; 2011 Aug; 47(12):1789-97. PubMed ID: 21612914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future of molecular profiling of human hepatocellular carcinoma.
    Roessler S; Budhu A; Wang XW
    Future Oncol; 2007 Aug; 3(4):429-39. PubMed ID: 17661718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic markers and putative therapeutic targets for hepatocellular carcinoma.
    Frau M; Biasi F; Feo F; Pascale RM
    Mol Aspects Med; 2010 Apr; 31(2):179-93. PubMed ID: 20176048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic profiling of human hepatocellular carcinoma.
    Lee JS; Thorgeirsson SS
    Semin Liver Dis; 2005; 25(2):125-32. PubMed ID: 15918141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients.
    El-Aneed A; Banoub J
    Anticancer Res; 2006; 26(5A):3293-300. PubMed ID: 17094443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional genomics of hepatocellular carcinoma.
    Thorgeirsson SS; Lee JS; Grisham JW
    Hepatology; 2006 Feb; 43(2 Suppl 1):S145-50. PubMed ID: 16447291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel oncogenes and tumor suppressors in hepatocellular carcinoma.
    Imbeaud S; Ladeiro Y; Zucman-Rossi J
    Semin Liver Dis; 2010 Feb; 30(1):75-86. PubMed ID: 20175035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage of endoplasmic reticulum proteins in hepatocellular carcinoma: Detection of generated fragments in patient sera.
    Chignard N; Shang S; Wang H; Marrero J; Bréchot C; Hanash S; Beretta L
    Gastroenterology; 2006 Jun; 130(7):2010-22. PubMed ID: 16762624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
    Gho JW; Ip WK; Chan KY; Law PT; Lai PB; Wong N
    Cancer Res; 2008 Aug; 68(16):6743-51. PubMed ID: 18701499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular biology and hepatocellular carcinoma: current status and future prospects].
    Saffroy R; Pham P; Lemoine A; Debuire B
    Ann Biol Clin (Paris); 2004; 62(6):649-56. PubMed ID: 15563423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatocellular carcinoma: molecular pathogenesis and novel targets for therapy].
    Marquardt JU; Galle PR; Teufel A
    Dtsch Med Wochenschr; 2012 Apr; 137(16):855-60. PubMed ID: 22495921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.